Diabetes mellitus - A risk factor for the development of osteoporosis;Dijabetes melitus - Faktor rizika od nastanaka osteoporoze

Vojnosanitetski Pregled

Volumn 65, Issue 9, 2008, Pages 692-698

  Vuksanović, Miljanka ^a   Durica, Snežana ^a   Žerajić, Branka ^a  

^a Centar za Plu ne Bolesti   (Serbia)

Author keywords

Diabetes mellitus, type 1; Diabetes mellitus, type 2; Osteoporosis; Risk factors

Indexed keywords

ESTROGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

BODY MASS; DIABETES MELLITUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; REVIEW; RISK FACTOR; PATHOPHYSIOLOGY;

DIABETES COMPLICATIONS; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 54049127002     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0809692V     Document Type: Review

References (35)

1. Rizzoli R. Atlas of postemnopausal osteoporosis. 2nd ed. Current Medicine Group LTD; 2005.
2. Vujović S. Menopause. Belgrade: School of Medicine; 1998. (Serbian)
3. Crossed D signurica S. Hormone induced osteoporosis. Belgrade: Grafolik; 2005. (Serbian)
4. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007; 22(9): 1317-1328 (Pubitemid 351339677)
5. Takamoto I, Kadowaki T. Diabetes and osteoporosis. Clin Calcium 2004; 14(2): 255-261 (Japanese)
6. Schwartz AV. Diabetes Mellitus: Does it Affect Bone? Calcif Tissue Int 2003; 73(6): 515-519
7. Raska I Jr, Broulík P. The impact of diabetes mellitus on skeletal health: an established phenomenon with inestablished causes? Prague Med Rep 2005; 106(2): 137-148
8. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001; 109 Suppl 2: S493-514.
9. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003; 33(4): 646-651 (Pubitemid 37222391)
10. Zayour D, Daouk M, Medawar W, Salamoun M, El-Hajj Fuleihan G. Predictors of bone mineral density in patients on hemodialysis. Transplant Proc 2004; 36(5): 1297-1301 (Pubitemid 38902961)
11. Jehle PM, Jehle DR, Mohan S, Böhm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol 1998; 159(2): 297-306. (Pubitemid 28520183)
12. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000; 23(5): 295-303. (Pubitemid 30426548)
13. Carnevale V, Romagnoli E, D'Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 2004; 20(3): 196-204. (Pubitemid 38714317)
14. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 1998; 41(11): 1314-1320 (Pubitemid 28488759)
15. McCabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 2007; 102(6): 1343-1357 (Pubitemid 350223938)
16. Rakić V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia 2006; 49(5): 863-871
17. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005; 146(8): 3622-3631 (Pubitemid 41058134)
18. Alexopoulou O, Jamart J, Devogelaer JP, Brichard S, de Nayer P, Buysschaert M. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab 2006; 32(5 Pt 1): 453-458 (Pubitemid 44836587)
19. Nicodemus KK, Folsom AR; Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24(7): 1192-1197 (Pubitemid 33716397)
20. Campos Pastor MM, López-Ibarra PJ, Escobar-Jiménez F, Serrano Pardo MD, García-Cervigón AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 2000; 11(5): 455-459 (Pubitemid 30450130)
21. Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 2003; 18(4): 784-790 (Pubitemid 36899328)
22. Tuominen JT, Impivaara O, Puukka P, Rönnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999; 22(7): 1196-1200 (Pubitemid 29293977)
23. Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25(10): 1749-1754 (Pubitemid 41071081)
24. Mascitelli L, Pezzetta F. Diabetes and osteoporotic fractures. CMAJ 2007; 177(11): 1391-1392 (Pubitemid 350207198)
25. Takeuchi Y. Metabolic bone diseases in patients with diabetes mellitus. Nippon Rinsho 2006; 64(9): 1697-1702 (Japanese)
26. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86(5): 1930-1935 (Pubitemid 32472900)
27. Bronský J, Průsa R. Amylin fasting plasma levels are decreased in patients with osteoporosis. Osteoporos Int 2004; 15(3): 243-247 (Pubitemid 38391541)
28. Cornish J, Naot D, Reid IR. Adrenomedullin - a regulator of bone formation. Regul Pept 2003; 112(1-3): 79-86. (Pubitemid 36351606)
29. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 2000; 278(6): G946-51. (Pubitemid 30439174)
30. Bronský J, Průsa R, Nevoral J. The role of amylin and related peptides in osteoporosis. Clin Chim Acta 2006; 373(1-2): 9-16. (Pubitemid 44376461)
31. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005; 289(5): E735-45. (Pubitemid 41504371)
32. Ilić J, Kovačev B. Diabetic osteopathy. Med Pregl 2005; 58(3-4): 147-152 (Serbian)
33. Buday B, Horváth T, Kulcsár E, Salamon C, Literáti Nagy B, Barta K, et al. Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status. Orv Hetil 2007; 148(24): 1127-1133 (Hungarian)
34. de Luis Román DA, Aller R, Perez Castrillon JL, De Luis J, Gonzalez Sagrado M, Izaola O, et al. Effects of dietary intake and life style on bone density in patients with diabetes mellitus type 2. Ann Nutr Metab 2004; 48(3): 141-145 (Pubitemid 39177718)
35. Wada S. Therapeutic approaches for diabetic osteopahty. Clin Calcium 2006; 16(8): 1297-1304 (Japanese)